During the first two days of the vaccination drive total of 447 adverse events were reported. While only three cases were initially hospitalized, two have already been discharged from AAIMS, New Delhi, and Northern railway Hospital, respectively, as per the health ministry.
“One case is still under observation in AIIMS Rishikesh and is fine,” additional health secretary Manohar Agnani said. Most of the adverse events reported so far are minor like fever, pain, headache, nausea, giddiness, and mild allergic reactions like rashes, etc.
Agnani said, “Protocols are in place for reporting, immediate case management; at vaccination session site, transportation and hospitalization, and further care of such cases. Protocols are also in place for systematic investigation and causality assessment of serious AEFIs.”
An adverse event following immunization (AEFI) is defined as any unexpected medical occurrence which follows vaccination. It may or may not be related to the vaccine or vaccination process.
India launched its first phase of the COVID vaccination programme; across the country on Saturday with two vaccines – Oxford University and AstraZeneca developed Covishield and Bharat Biotech’s Covaxin, developed in collaboration; with the Indian Council of Medical Research. A total of 2,24,301 beneficiaries were vaccinated so far. On Sunday, 17,072 beneficiaries who were inoculated in 553 sessions across six states; have been advised to plan COVID vaccination sessions 4 days a week to minimise disruption of routine health service.